imipramine has been researched along with vasoactive intestinal peptide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dunér-Engström, M; Fahrenkrug, J; Fredholm, BB; Larsson, O; Lundberg, JM; Lundblad, L | 1 |
Chiba, S; Furukawa, Y; Karasawa, Y; Murakami, M; Narita, M; Ren, LM; Takei, M | 1 |
2 other study(ies) available for imipramine and vasoactive intestinal peptide
Article | Year |
---|---|
Effects of acute and long-term atropine treatment on levels, release and response to VIP and PHI in the submandibular gland of cat and rat.
Topics: Adenylyl Cyclases; Animals; Atropine; Cats; Cyclic AMP; Guanosine Triphosphate; Imipramine; Male; Organ Size; Parasympathetic Nervous System; Peptide PHI; Rats; Rats, Sprague-Dawley; Submandibular Gland; Vasoactive Intestinal Peptide | 1992 |
Cardiac responses to VIP and VIP-ergic-cholinergic interaction in isolated dog heart preparations.
Topics: Animals; Dogs; Electric Stimulation; Electrocardiography; Heart; Heart Rate; Imipramine; In Vitro Techniques; Myocardial Contraction; Norepinephrine; Parasympathetic Nervous System; Propranolol; Swine; Tetrodotoxin; Vasoactive Intestinal Peptide | 1990 |